Delivering 3 billion doses of Comirnaty in 2021

Nat Biotechnol. 2023 Feb;41(2):183-188. doi: 10.1038/s41587-022-01643-1.

Authors

Nicholas Warne¹, Margaret Ruesch¹, Pamela Siwik¹, Paul Mensah¹, John Ludwig¹, Michael Hripcsak¹, Ranga Godavarti¹, Andrew Prigodich¹, Mikael Dolsten²

Affiliations

¹ Pfizer, New York, NY, USA.
² Pfizer, New York, NY, USA. mikael.dolsten@pfizer.com.

PMID: 36732478
DOI: 10.1038/s41587-022-01643-1

No abstract available

MeSH terms

BNT162 Vaccine*
Vaccine Development*

Substances

BNT162 Vaccine